List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 39 studies with search of: Aldesleucina OR Proleukin [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Conditions: Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Aldesleukin
2 Completed Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Condition: HIV Infections
Intervention: Drug: Aldesleukin
3 Completed A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
4 Completed
Has Results 		Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)
Condition: HIV Infection
Intervention: Drug: Proleukin
5 Completed A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
6 Completed
Has Results 		An International Study to Evaluate Recombinant Interleukin-2 (rIL-2) in HIV Positive Patients Taking Anti-retroviral Therapy
Condition: HIV Infections
Intervention: Drug: Recombinant interleukin-2 (rIL-2)
7 Completed Interleukin-2 With and Without Antiretroviral Therapy to Treat HIV-1 Infection
Conditions: HIV Infections;   HIV
Intervention: Drug: Interleukin-2, Proleukin
8 Unknown † A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Stavudine;   Drug: Didanosine;   Drug: Aldesleukin
9 Completed Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Interventions: Drug: Aldesleukin;   Drug: ART
10 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
11 Unknown † Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
12 Completed The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
13 Completed A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
14 Active, not recruiting Novel Interventions in HIV-1
Condition: HIV-1 Infection
Interventions: Biological: GTU-MultiHIV B clade vaccine1mg;   Drug: Interleukin-2;   Drug: GM-CSF;   Drug: Growth Hormone
15 Completed Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin
16 Completed Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin
17 Unknown † Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Aldesleukin
18 Completed Effect of Interleukin-2 on HIV Treatment Interruption
Condition: HIV Infections
Intervention: Drug: Aldesleukin
19 Completed A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Aldesleukin
20 Completed Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin;   Drug: Aldesleukin;   Drug: Peginterferon alfa-2b

Previous Page Studies Shown (1-20) Next Page (21-39)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services